BCMTMS Regulatory, Billing and Practice Management Study Guide

50+ PAGE PDF – BCMTMS Regulatory, Billing, and Practice Management Study Guide

About 30% of the BCMTMS exam will entail questions about public health, regulatory agencies, ambulatory care practice, and statistics.  With this new resource and our stats study guide, you will better be able to prepare for and pass your exam.  We used critical concepts from the content outline and explained them in simple, plain English.

Here’s a list of the topics covered in the study guide:

  • Food and Drug Administration (FDA)
  • MedWatch
  • Center for Drug Evaluation and Research (CDER)
  • Center for Biologics Evaluation and Research (CBER)
  • Biologics License Application (BLA)
  • Purple Book and Orange Book
  • Division of Medication Error Prevention and Analysis (DMEPA)
  • Institute of Safe Medicine Practices (ISMP)
  • ISMP Medication Errors Reporting Program (MERP)
  • ISMP Vaccine Errors Reporting Program (VERP)
  • Vaccine Adverse Event Reporting System (VAERS)
  • United States Pharmacopeia (USP)
  • National Institute of Health (NIH)
  • Agency for Healthcare Quality and Research (AHQR)
  • Institute of Medicine (IOM)
  • Medication Errors
  • Just Culture
  • Accountable Care Organization (ACO)
  • National Quality Forum (NQF)
  • Meaningful Use
  • Conflicts of interest (ethics)
  • Training Students and Residents
  • Primary Care Clinical Pharmacy Peer Review Data Collection Sheet
  • Transtheoretical Model of Change (Stages of Making a Change)
  • The Health Belief Model
  • Educating Healthcare Professionals and Patients
  • Health Literacy
  • Single Item Literacy Screener
  • Cultural/Religious Considerations with Medication Use
  • National Committee for Quality Assurance (NCQA)
  • Healthcare Effectiveness Data and Information Set (HEDIS measures)
  • Health Level-7 Standards (HL7)
  • PHI (Protected Health Information)
  • Health Insurance Portability and Accountability Act (HIPAA)
  • Centers for Medicare and Medicaid (CMS)
  • Medicare Part A
  • Medicare Part B
  • Medicare Part C
  • Medicare Part D
  • Children’s Health Insurance Program
  • Health Insurance Marketplace
  • CMS Innovation Center
  • Risk Evaluation and Mitigation Strategy (REMS)
  • Elements to Assure Safe Use (ETASU) – part of the REMS program
  • OSHA (Occupational Safety and Health Administration)
  • Biologics Control Act of 1902
  • Food and Drugs Act of 1906
  • 1938 Food, Drug, and Cosmetic Act
  • Durham-Humphrey Amendment of 1951
  • Kefauver-Harris of 1962
  • Tamper Resistant Packaging Regulation of 1982
  • Orphan Drug Act of 1983
  • Prescription Drug Marketing Act (1988)
  • 1993 – Medwatch Created
  • Dietary Supplement Health and Education Act (DSHEA) – 1994
  • FDA Modernization Act of 1997
  • Medicare Prescription Drug Improvement and Modernization Act of 2003
  • The Affordable Care Act of 2010 (AKA Obamacare)
  • Institutional Review Board (IRB)
  • Plan-Do Study-Act (PDSA) – Quality Improvement Method
  • Six Sigma – Quality Improvement Method
  • Medication Use Evaluation (MUE)
  • Process Improvement Tools
  • Swiss Cheese Effect
  • Failure Mode and Effects Analysis (FMEA)
  • Plan-Do-Study-Act (PDSA)
  • Root Cause Analysis
  • Formulary
  • Pharmacy and Therapeutics Committee (P&T)
  • Cost-Minimization Analysis
  • Cost-Effectiveness Analysis
  • Cost-Utility Analysis
  • Cost-Benefit Analysis
  • Collaborative Practice Agreement (CPA) for Pharmacists
  • Scope of Practice
  • Ambulatory Care Practice
  • Ambulatory Care Revenue
  • General Versus Direct Supervision
  • Diabetes Education
  • Point-of-Care Testing
  • Medication Therapy Management
  • Comprehensive Medication Review
  • Targeted Medication Review
  • Medication Therapy Management Platforms
  • Enhanced MTM
  • CMS Star Ratings
  • Comprehensive Medication Management
  • Situation Background Assessment Resolution (SBAR)
  • Subjective, Objective, Assessment, Plan (SOAP)
  • Screening, Brief Intervention, and Referral to Treatment for Substance Use (SBIRT)
  • Telehealth Advantages and Disadvantages
  • Remote Patient Monitoring
  • Communication Barriers
  • Language and Cultural Barriers
  • Cognition or Memory Barriers
  • Sensory Barriers
  • Health Literacy Barriers
  • Soft Dollar Revenue Model
  • Ambulatory Care Costs
  • Developing an Ambulatory Practice
  • Academic Detailing
  • Motivational Interviewing
  • Medicare Access and CHIP Reauthorization Act (MACRA)
  • Merit-based Incentive Payment System (MIPS)
  • Physician Quality Reporting System
  • Hospice Care
  • General Power of Attorney
  • Palliative Care


I cannot thank you enough – very much appreciated- the charts / tests and slides had a huge impact on my passing the BCPS. Your site made a huge difference and is very well organized. I really feel you covered the areas Pharmacology, Regulatory, and Biostatistics very well.

Joseph Dougherty

I would like to say thank you for your BCPS study material. Having practiced as a pharmacist for just over 10 years in Australia, I have always try to keep myself up-to-date with current guidelines, the latest evidence, and clinical knowledge. However, having failed twice previously, I needed guidance that is succinct and focused on pharmacotherapy and pharmacy practice in the US context – your study material provided exactly that. I have done basic biostatistics post-graduate and your stat study guide was a good revision for me (especially the table showing an overview of important statistical tests). I think your recently-added regulatory study guide was what really pushed me over the pass mark – that 32-page was enough for me to understand the important roles each organization plays in the US healthcare system.

Alex Chan

I purchased both courses from ASHP and ACCP. Your questions give the material from ACCP a run for its money, inasmuch as you present valid, valuable clinical information.

Mary B.

I was surprised by the ease it took me to understand the key concepts while reviewing your BCPS study guide. It was very reader-friendly and well written. For someone like me who has not had enough exposure to statistics, let alone biostatistics, it was of tremendous value.

Mike M.

The questions on this exam are similar in format and content to the actual NAPLEX exam. It’s an affordable way to assess your preparation and help you identify areas for additional study.

Alissa G.

The questions are great and so are the explanations- it’s so much easier to learn from a peer. Thank you for being willing to do this!

Jessica H.

Thanks for providing the mock exam – it was a big help for me.

Maria V.